{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T02:52:51Z","timestamp":1767495171763},"reference-count":30,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["2011-2383"],"award-info":[{"award-number":["2011-2383"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007687","name":"Swedish Society of Medicine","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Uppsala University and Lars Hierta Memorial Foundation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Research"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.neures.2013.07.008","type":"journal-article","created":{"date-parts":[[2013,8,7]],"date-time":"2013-08-07T06:30:49Z","timestamp":1375857049000},"page":"102-109","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Muscle-specific regulation of the mTOR signaling pathway in MuSK antibody seropositive (MuSK+) experimental autoimmune Myasthenia gravis (EAMG)"],"prefix":"10.1016","volume":"77","author":[{"given":"Mayank","family":"Chauhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanel","family":"Punga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Rostedt","family":"Punga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neures.2013.07.008_bib0005","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.cmet.2008.10.002","article-title":"Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy","volume":"8","author":"Bentzinger","year":"2008","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.neures.2013.07.008_bib0010","first-page":"295","article-title":"New insights into the roles of agrin. Nature reviews","volume":"4","author":"Bezakova","year":"2003","journal-title":"Molecular Cell Biology"},{"key":"10.1016\/j.neures.2013.07.008_bib0015","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1126\/science.1065874","article-title":"Identification of ubiquitin ligases required for skeletal muscle atrophy","volume":"294","author":"Bodine","year":"2001","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.neures.2013.07.008_bib0020","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jns.2011.12.016","article-title":"Neurophysiological characteristics of MuSK antibody positive myasthenia gravis mice: focal denervation and hypersensitivity to acetylcholinesterase inhibitors","volume":"316","author":"Chroni","year":"2012","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.neures.2013.07.008_bib0025","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nature06322","article-title":"mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex","volume":"450","author":"Cunningham","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.neures.2013.07.008_bib0030","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.neures.2013.07.008_bib0035","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/awl095","article-title":"MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis","volume":"129","author":"Farrugia","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.neures.2013.07.008_bib0040","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.biocel.2005.04.018","article-title":"Skeletal muscle hypertrophy and atrophy signaling pathways","volume":"37","author":"Glass","year":"2005","journal-title":"International Journal of Biochemistry and Cell Biology"},{"key":"10.1016\/j.neures.2013.07.008_bib0045","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1177\/41.5.8468455","article-title":"The histochemical profiles of fast fiber types IIB, IID, and IIA in skeletal muscles of mouse, rat, and rabbit","volume":"41","author":"Hamalainen","year":"1993","journal-title":"The Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society"},{"key":"10.1016\/j.neures.2013.07.008_bib0050","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.mcn.2005.10.020","article-title":"Synapse disassembly and formation of new synapses in postnatal muscle upon conditional inactivation of MuSK","volume":"31","author":"Hesser","year":"2006","journal-title":"Molecular and Cellular Neurosciences"},{"key":"10.1016\/j.neures.2013.07.008_bib0055","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nature Medicine"},{"key":"10.1016\/j.neures.2013.07.008_bib0060","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1016\/j.febslet.2008.10.021","article-title":"FGF21 is an Akt-regulated myokine","volume":"582","author":"Izumiya","year":"2008","journal-title":"FEBS Letters"},{"key":"10.1016\/j.neures.2013.07.008_bib0065","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/sj.embor.7400065","article-title":"Inhibition of synapse assembly in mammalian muscle in vivo by RNA interference","volume":"5","author":"Kong","year":"2004","journal-title":"EMBO Reports"},{"key":"10.1016\/j.neures.2013.07.008_bib0070","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.neures.2013.07.008_bib0075","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2478\/aoj-2006-0010","article-title":"Myosin heavy chain isoform composition of human masseter muscle from subjects with different mandibular plane angles","volume":"22","author":"Lim","year":"2006","journal-title":"Australian Orthodontic Journal"},{"key":"10.1016\/j.neures.2013.07.008_bib0080","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: navigating downstream","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.neures.2013.07.008_bib0085","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s12311-008-0087-z","article-title":"PPAR-gamma agonist Azelaoyl PAF increases frataxin protein and mRNA expression: new implications for the Friedreich's ataxia therapy","volume":"8","author":"Marmolino","year":"2009","journal-title":"Cerebellum"},{"key":"10.1016\/j.neures.2013.07.008_bib0090","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.neures.2013.07.008_bib0095","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.expneurol.2011.04.018","article-title":"Muscle-selective synaptic disassembly and reorganization in MuSK antibody positive MG mice","volume":"230","author":"Punga","year":"2011","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.neures.2013.07.008_bib0100","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1460-9568.2010.07569.x","article-title":"MuSK levels differ between adult skeletal muscles and influence postsynaptic plasticity","volume":"33","author":"Punga","year":"2011","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/j.neures.2013.07.008_bib0105","doi-asserted-by":"crossref","first-page":"12239","DOI":"10.1073\/pnas.220403797","article-title":"Frataxin activates mitochondrial energy conversion and oxidative phosphorylation","volume":"97","author":"Ristow","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.neures.2013.07.008_bib0110","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.clinph.2006.03.028","article-title":"Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes","volume":"117","author":"Rostedt Punga","year":"2006","journal-title":"Clinical Neurophysiology"},{"key":"10.1016\/j.neures.2013.07.008_bib0115","doi-asserted-by":"crossref","first-page":"C1248","DOI":"10.1152\/ajpcell.00104.2009","article-title":"Smad2 and 3 transcription factors control muscle mass in adulthood","volume":"296","author":"Sartori","year":"2009","journal-title":"American Journal of Physiology. Cell Physiology"},{"key":"10.1016\/j.neures.2013.07.008_bib0120","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.bbamcr.2010.09.019","article-title":"Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network","volume":"1813","author":"Scarpulla","year":"2011","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.neures.2013.07.008_bib0125","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2044-5040-1-4","article-title":"Regulation of skeletal muscle growth by the IGF1-Akt\/PKB pathway: insights from genetic models","volume":"1","author":"Schiaffino","year":"2011","journal-title":"Skeletal Muscle"},{"key":"10.1016\/j.neures.2013.07.008_bib0130","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1172\/JCI21545","article-title":"Induction of myasthenia by immunization against muscle-specific kinase","volume":"116","author":"Shigemoto","year":"2006","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.neures.2013.07.008_bib0135","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.coph.2008.01.005","article-title":"Congenital muscle disorders with cores: the ryanodine receptor calcium channel paradigm","volume":"8","author":"Treves","year":"2008","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/j.neures.2013.07.008_bib0140","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/jnnp.48.12.1246","article-title":"Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays","volume":"48","author":"Vincent","year":"1985","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/j.neures.2013.07.008_bib0145","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1385\/JMN:30:1:223","article-title":"MuSK signaling at the neuromuscular junction","volume":"30","author":"Wang","year":"2006","journal-title":"Journal of Molecular Neuroscience"},{"key":"10.1016\/j.neures.2013.07.008_bib0150","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1552-6569.2009.00456.x","article-title":"MRI evidence of early muscle atrophy in MuSK positive myasthenia gravis","volume":"21","author":"Zouvelou","year":"2011","journal-title":"Journal of Neuroimaging"}],"container-title":["Neuroscience Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168010213001855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168010213001855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T03:54:04Z","timestamp":1715831644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168010213001855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":30,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0168010213001855"],"URL":"https:\/\/doi.org\/10.1016\/j.neures.2013.07.008","relation":{},"ISSN":["0168-0102"],"issn-type":[{"value":"0168-0102","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Muscle-specific regulation of the mTOR signaling pathway in MuSK antibody seropositive (MuSK+) experimental autoimmune Myasthenia gravis (EAMG)","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neures.2013.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}